Haley Ellis

机构：Massachusetts General Hospital · ORCID：0000-0002-4915-9640

发表论文 105 篇 · 总被引 2748 次 · h-index 17

代表论文

• Genomic landscape of clinically acquired resistance alterations in patients treated with KRASG12C inhibitors (2025 · Annals of Oncology · 被引 57)
• Generation of a Biliary Tract Cancer Cell Line Atlas Identifies Molecular Subtypes and Therapeutic Targets (2025 · Cancer Discovery · 被引 15)
• MAPK Pathway Mutations Emerge in Mutant IDH1 Inhibitor–Resistant Cholangiocarcinoma and Attenuate the IFN Response (2025 · Clinical Cancer Research · 被引 4)
• Percutaneous Endobiliary Radiofrequency Ablation (PERFA) for Unresectable Cholangiocarcinoma (2026 · Academic Radiology · 被引 2)
• Diagnostic Performance of PSMA PET/MRI in Characterizing LI-RADS 3 Observations in Patients with Cirrhosis (2025 · Journal of Nuclear Medicine · 被引 1)
• A multicenter, open-label, first-in-human study of TYRA-200 in advanced intrahepatic cholangiocarcinoma and other solid tumors with activating FGFR2 gene alterations (SURF201). (2025 · Journal of Clinical Oncology · 被引 1)